Literature DB >> 27943502

Pilot randomized, non-inferiority, cross-over trial of once-weekly vs. three times-weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A.

M V Ragni1,2, J G Yabes3, P F Fogarty4, N C Josephson5, C M Kessler6, A T Neff7, L Raffini8, K Brummel-Ziedins9, C G Moore3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27943502      PMCID： PMC5226871          DOI： 10.1111/hae.13131

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  13 in total

1.  Rationale for a randomized controlled trial comparing two prophylaxis regimens in adults with severe hemophilia A: the Hemophilia Adult Prophylaxis Trial.

Authors:  Margaret V Ragni
Journal:  Expert Rev Hematol       Date:  2011-10       Impact factor: 2.929

2.  The paradoxical problem with multiple-IRB review.

Authors:  Jerry Menikoff
Journal:  N Engl J Med       Date:  2010-10-13       Impact factor: 91.245

3.  Thrombin generation and bleeding in haemophilia A.

Authors:  K E Brummel-Ziedins; M F Whelihan; M Gissel; K G Mann; G E Rivard
Journal:  Haemophilia       Date:  2009-06-26       Impact factor: 4.287

Review 4.  Recommendations for planning pilot studies in clinical and translational research.

Authors:  Charity G Moore; Rickey E Carter; Paul J Nietert; Paul W Stewart
Journal:  Clin Transl Sci       Date:  2011-10       Impact factor: 4.689

5.  The longitudinal effect of body adiposity on joint mobility in young males with Haemophilia A.

Authors:  J M Soucie; C Wang; A Siddiqi; R Kulkarni; M Recht; B A Konkle
Journal:  Haemophilia       Date:  2011-03       Impact factor: 4.287

6.  Factor VIII prophylaxis for adult patients with severe haemophilia A: results of a US survey of attitudes and practices.

Authors:  C E Walsh; L A Valentino
Journal:  Haemophilia       Date:  2009-06-01       Impact factor: 4.287

7.  Effects of secondary prophylaxis started in adolescent and adult haemophiliacs.

Authors:  A Tagliaferri; M Franchini; A Coppola; G F Rivolta; C Santoro; G Rossetti; G Feola; E Zanon; A Dragani; P Iannaccaro; P Radossi; P M Mannucci
Journal:  Haemophilia       Date:  2008-06-05       Impact factor: 4.287

8.  Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.

Authors:  Marilyn J Manco-Johnson; Thomas C Abshire; Amy D Shapiro; Brenda Riske; Michele R Hacker; Ray Kilcoyne; J David Ingram; Michael L Manco-Johnson; Sharon Funk; Linda Jacobson; Leonard A Valentino; W Keith Hoots; George R Buchanan; Donna DiMichele; Michael Recht; Deborah Brown; Cindy Leissinger; Shirley Bleak; Alan Cohen; Prasad Mathew; Alison Matsunaga; Desiree Medeiros; Diane Nugent; Gregory A Thomas; Alexis A Thompson; Kevin McRedmond; J Michael Soucie; Harlan Austin; Bruce L Evatt
Journal:  N Engl J Med       Date:  2007-08-09       Impact factor: 91.245

9.  Development and testing of an instrument to assess the Quality of Life of Children with Haemophilia in Europe (Haemo-QoL).

Authors:  S von Mackensen; M Bullinger
Journal:  Haemophilia       Date:  2004-03       Impact factor: 4.287

10.  A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management.

Authors:  L A Valentino; V Mamonov; A Hellmann; D V Quon; A Chybicka; P Schroth; L Patrone; W-Y Wong
Journal:  J Thromb Haemost       Date:  2012-03       Impact factor: 5.824
View more
  3 in total

Review 1.  Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B.

Authors:  Omotola O Olasupo; Megan S Lowe; Ashma Krishan; Peter Collins; Alfonso Iorio; Davide Matino
Journal:  Cochrane Database Syst Rev       Date:  2021-08-18

2.  Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patients.

Authors:  Hassan Abolghasemi; Yunes Panahi; Minoo Ahmadinejad; Gholamreza Toogeh; Mehran Karimi; Aziz Eghbali; Nargess Bigom Mirbehbahani; Bighan Keikhaei Dehdezi; Zahra Badiee; Hamid Hoorfar; Peyman Eshghi; Nader Maghsoudi; Amirhossein Sahebkar; Mohammad Gholami-Fesharaki
Journal:  J Pharmacopuncture       Date:  2018-06-30

Review 3.  Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations.

Authors:  Alfonso Iorio; Andrea N Edginton; Victor Blanchette; Jan Blatny; Ana Boban; Marjon Cnossen; Peter Collins; Stacy E Croteau; Katheljin Fischer; Daniel P Hart; Shinya Ito; Joan Korth-Bradley; Stefan Lethagen; David Lillicrap; Mike Makris; Ron Mathôt; Massimo Morfini; Ellis J Neufeld; Jeffrey Spears
Journal:  Res Pract Thromb Haemost       Date:  2018-05-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.